No Image

$OMER

October 9, 2012 Michele 0

Omeros, clinical stage biopharmaceutical company, announced on 10/3, the completion of enrollment in OMS302 phase 3 clinical trial. OMS302 ┬áis one of Omero’s proprietary PharmocoSurgery […]

No Image

$MO

October 9, 2012 Michele 0

Altria group Inc, manufacturer of cigarettes, smokeless products, and wine in the US, is a P/E of 15.7 , below the average tobacco industry PE. […]